ES2170654A1 - Perfeccionamientos introducidos en el objeto de la patente p9900757, por un procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes. - Google Patents

Perfeccionamientos introducidos en el objeto de la patente p9900757, por un procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes.

Info

Publication number
ES2170654A1
ES2170654A1 ES200000933A ES200000933A ES2170654A1 ES 2170654 A1 ES2170654 A1 ES 2170654A1 ES 200000933 A ES200000933 A ES 200000933A ES 200000933 A ES200000933 A ES 200000933A ES 2170654 A1 ES2170654 A1 ES 2170654A1
Authority
ES
Spain
Prior art keywords
mixture
gamma globulin
preparation
animal origin
plasma proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200000933A
Other languages
English (en)
Other versions
ES2170654B1 (es
Inventor
Pozo Francisco J Polo
Canel Carmen Rodriguez
Navarro Jesus Rodenas
Martin Maria Nieves Saborido
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
APC Europe SA
Original Assignee
APC Europe SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by APC Europe SA filed Critical APC Europe SA
Priority to DE60021644T priority Critical patent/DE60021644D1/de
Priority to AT00500066T priority patent/ATE300956T1/de
Priority to ES00500066T priority patent/ES2243223T3/es
Priority to EP00500066A priority patent/EP1044690B1/en
Publication of ES2170654A1 publication Critical patent/ES2170654A1/es
Application granted granted Critical
Publication of ES2170654B1 publication Critical patent/ES2170654B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Perfeccionamientos introducidos en el objeto de la Patente P9900757, por un procedimiento para la obtención de gammaglobulinas de origen animal y aplicaciones correspondientes, que consisten en una aplicación de una mezcla de proteínas plasmáticas con un contenido en gammaglobulina superior al 25% en peso para la preparación de composiciones medicamentosas, preparados alimenticios y dietéticos: [a] aptos para la prevención y tratamiento de enfermedades gastrointestinales en humanos y animales, [b] aptos para la mejora del estado inmunológico en humanos y animales, [c] aptos para el tratamiento de procesos de malabsorción en humanos y animales, y [d] aptos para el tratamiento de situaciones clínicas que cursan con desnutrición en humanos y animales.
ES200000933A 1999-04-13 2000-04-11 Perfeccionamientos introducidos en el objeto de la patente p9900757, por un procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes. Expired - Fee Related ES2170654B1 (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE60021644T DE60021644D1 (de) 1999-04-13 2000-04-12 Anwendung und Herstellungsverfahren von tierischen Gammaglobulin-reichen Plasmaprotein Mischungen
AT00500066T ATE300956T1 (de) 1999-04-13 2000-04-12 Anwendung und herstellungsverfahren von tierischen gammaglobulin-reichen plasmaprotein mischungen
ES00500066T ES2243223T3 (es) 1999-04-13 2000-04-12 Aplicaciones de mezclas de proteinas plasmaticas de origen animal en gammaglobulinas y procedimiento para su preparacion.
EP00500066A EP1044690B1 (en) 1999-04-13 2000-04-12 Applications of gamma globulin-rich plasma protein mixtures of animal origin and process for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9900757A ES2158776B1 (es) 1999-04-13 1999-04-13 Procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes.

Publications (2)

Publication Number Publication Date
ES2170654A1 true ES2170654A1 (es) 2002-08-01
ES2170654B1 ES2170654B1 (es) 2003-06-16

Family

ID=8308004

Family Applications (2)

Application Number Title Priority Date Filing Date
ES9900757A Expired - Fee Related ES2158776B1 (es) 1999-04-13 1999-04-13 Procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes.
ES200000933A Expired - Fee Related ES2170654B1 (es) 1999-04-13 2000-04-11 Perfeccionamientos introducidos en el objeto de la patente p9900757, por un procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES9900757A Expired - Fee Related ES2158776B1 (es) 1999-04-13 1999-04-13 Procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes.

Country Status (1)

Country Link
ES (2) ES2158776B1 (es)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0064210A1 (en) * 1981-05-01 1982-11-10 Miles Inc. Oral pharmaceutical composition containing immune globulin
EP0338229A1 (de) * 1988-04-19 1989-10-25 Biotest Pharma Gmbh Präparat mit Antikörperaktivität und breitem Wirkungsspektrum, daraus bestehende oder diese enthaltende Mittel und deren Verwendung zur Behandlung von bakteriell oder toxin-bedingten Erkrankungen und zur Bekämpfung von Protozoen
US5122373A (en) * 1983-03-16 1992-06-16 Immuno Aktiengesellschaft Immunoglobulin-g-containing fraction
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
WO1999064462A1 (en) * 1998-06-09 1999-12-16 Statens Serum Institut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2672303B2 (ja) * 1987-06-22 1997-11-05 財団法人 化学及血清療法研究所 馬用感染予防治療剤
JP2613409B2 (ja) * 1987-11-20 1997-05-28 株式会社ミドリ十字 抗エイズウイルス抗体陽性静注用免疫グロブリン製剤の製造方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0064210A1 (en) * 1981-05-01 1982-11-10 Miles Inc. Oral pharmaceutical composition containing immune globulin
US5122373A (en) * 1983-03-16 1992-06-16 Immuno Aktiengesellschaft Immunoglobulin-g-containing fraction
EP0338229A1 (de) * 1988-04-19 1989-10-25 Biotest Pharma Gmbh Präparat mit Antikörperaktivität und breitem Wirkungsspektrum, daraus bestehende oder diese enthaltende Mittel und deren Verwendung zur Behandlung von bakteriell oder toxin-bedingten Erkrankungen und zur Bekämpfung von Protozoen
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
WO1999064462A1 (en) * 1998-06-09 1999-12-16 Statens Serum Institut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products

Also Published As

Publication number Publication date
ES2158776A1 (es) 2001-09-01
ES2170654B1 (es) 2003-06-16
ES2158776B1 (es) 2002-03-16

Similar Documents

Publication Publication Date Title
GEP19981289B (en) Method for Preparing Preserved Medicinal Means Containing Human Protein and Medicinal Means
WO1998026747A3 (en) Superantigen based methods and compositions for treatment of diseases
BG109311A (en) PHARMACEUTICAL COMPOSITION, INCLUDING HUMAN ANTIBODIES CONNECTING HUMAN TNFAL, AND HIS APPLICATION
AU1261583A (en) N-glycosylated carboxamide derivatives
WO1997017446A3 (en) HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
IL112665A0 (en) 5-substituted derivatives of mycophenolic acid, their preparation and pharmaceutical compositions containing them
BR9712259A (pt) Colostrininin, uso do mesmo, processos de tratar distúrbios do sistema nervoso central e/ou do sistema imune, de preparar colostrinin de colostro de mamìferos e de produzir uma composição farmacêutica, composição farmacêutica, suplemento dietético, nanopeptìdeo, e, uso do mesmo.
PT914114E (pt) Metodos de tratamento de hipersensibilidade de tipo i utilizando monofosforil lipido a
WO1995019435A3 (en) T cell antigen receptor v region proteins and methods of preparation thereof
IE871967L (en) Binding-factor-related polypeptides
DE3584775D1 (de) Zusammensetzung zur behandlung von an haemophilia-a-inhibitor leidenden kranken.
BE900012A (fr) Nouveau peptide.
WO1996013498A3 (en) L-erythrosyl nucleosides
ZA935918B (en) Anti-cancer therapeutic compositions for prophylais or for treatment of cancer
ES2170654A1 (es) Perfeccionamientos introducidos en el objeto de la patente p9900757, por un procedimiento para la obtencion de gammaglobulinas de origen animal y aplicaciones correspondientes.
WO2001040465A3 (en) Compositions and methods for the treatment of immune related diseases
EP0955366A4 (en) ANTIGENIC PROTEIN FROM MALASSEZIA
BG96324A (bg) Фармакологично активно вещество врс, метод за неговото получаване и терапевтичното му приложение
Carding et al. Multiple proteins related to the soluble galactose-binding animal lectin revealed by a monoclonal anti-lectin antibody
EP0642333A4 (en) METHOD AND COMPOSITION FOR THE TREATMENT OF DISORDERS ASSOCIATED WITH IMMUNOLOGICAL DYSFUNCTION.
WO2000015797A3 (en) Compositions and methods for the treatment of immune related diseases
DE60021644D1 (de) Anwendung und Herstellungsverfahren von tierischen Gammaglobulin-reichen Plasmaprotein Mischungen
WO1998011246A3 (en) ENDO-β-GALACTOSIDASE
IE840977L (en) Pharmaceutical preparations
Götze et al. The induction of macrophage spreading by factor B of the properdin system

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20020801

Kind code of ref document: A1

Effective date: 20020801

FG2A Definitive protection

Ref document number: 2170654B1

Country of ref document: ES

FD1A Patent lapsed

Effective date: 20100312